Pay in 4 interest-free payments of $6.69 Learn more
Ships within 48 hours · Estimated delivery Sep 27 - Oct 2
1 In the Surpass-Early trial, nearly 800 adults diagnosed with type 2 diabetes within the past four years were assigned to add either tirzepatide, sold as 1 Most patients in the control group received other GLP-1 drugs including semaglutide, sold by Novo Nordisk as Ozempic and Rybelsus, or Lilly's own dulaglutide
FDA Approves New Medication for Chronic Weight Management. U.S
Because of its patent, Novo Nordisk is able to charge whatever it wants and according to the Institute for Clinical and Economic Review, Novo Nordisk is grossly overcharging
But over time, research tells us that that gap narrows
Retatrutide's price has not been announced, as the drug has not yet received FDA approval
Run concurrently
US$ 22.20
US$ 28.35
US$ 24.56
US$ 29.77
US$ 29.49
